WGS · GeneDx Holdings Corp
United States · RS rating 50 · As of 2026-11-03
| Price | 68.64 USD |
|---|---|
| 1-day change | +7.1% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 35 / 62 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 33 / 22 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +72.2% |
| Sales growth Q/Q | +3.6% |
| Distance from 52-week high | +59.0% |
| Market cap (USD) | $1.9B |